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MiceIt has been demonstrated that the exposure of rodents to the standard elevated plus-maze (sEPM: 2 open and
2 enclosed arms) elicits defensive behavioral reactions and antinociception and also activates the
hypothalamo-pituitary-adrenal (HPA) axis. We have recently reported that EPM-induced antinociception is
particularly observed when rats and mice are exposed to a totally open EPM (oEPM: 4 open arms). Given that
the oEPM seems to be a more aversive situation than the sEPM, we hypothesized that oEPM exposure would
induce higher plasma levels of corticosterone than sEPM exposure in mice. In this study, we investigated the
inﬂuence of exposure to eEPM (enclosed EPM: 4 enclosed arms), sEPM or oEPM on plasma corticosterone
levels in mice, with or without prior nociceptive stimulation (2.5% formalin injection into the right hind paw).
We also tested whether the nociceptive response in the formalin test and oEPM-induced antinociception are
altered by adrenalectomy. Results showed that oEPM-exposed mice spent less time licking the injected paw
than sEPM- and eEPM-exposed animals. All three types of EPM exposure increased plasma corticosterone
when compared to the basal group, but sEPM- and oEPM-exposed mice showed higher corticosterone levels
than eEPM-exposed mice. Prior nociceptive stimulation (formalin injection) did not enhance the plasma
corticosterone response induced by the three types of EPM exposure. Indeed, formalin injection appeared to
provoke a ceiling effect on plasma corticosterone concentration. Furthermore, neither the nociceptive
response in the formalin test nor oEPM-induced antinociception was changed by adrenalectomy. Present
results suggest that oEPM antinociception does not depend on corticosterone release in mice.de de Ciências Farmacêuticas –
aquara, SP, Brazil. Fax: +55 16
uza@pq.cnpq.br
evier OA license.© 2011 Elsevier Inc. Open access under the Elsevier OA license.Introduction
Threatening or aversive events can activate the hypothalamo-
pituitary-adrenocortical (HPA) axis and consequently, stimulate the
secretion of glucocorticoids from the adrenal cortex (e.g., Marin et al.,
2007). Glucocorticoids, especially cortisol in primates and corticoste-
rone in rodents, act on the expression and regulation of genes
throughout the body and affect many physiological process, that
prepare the organism for the changes in energy and metabolism
required when it is coping with stressful situations (Akil and Morano,
1995; Levine, 2005;Marin et al., 2007). Therefore, serum corticosterone
level is widely accepted as a biological marker of stress (Herman et al.,
2005; Korte, 2001).In general, activation of the HPA axis also attenuates pain sensitivity
(Lariviere and Melzack, 2000; Vissers et al., 2004; Yarushkina, 2008;
Yokoro et al., 2003). For instance, systemic administration of glucocor-
ticoids at physiological doses, so as to produce an increase in blood
hormones comparable to those seen in a stressful situation, leads to
reduction in the nociceptive response in rats (Yarushkina, 2008).
However, Yarushkina (2008) also emphasized a linear correlation
between the corticosterone level and the pain threshold, demonstrating
that the blockade of HPA functionwith an intra-hypothalamus injection
of the exogenous corticoid dexamethasone (at pharmacological doses)
completely eliminated the stress-induced analgesia. The samepatternof
results was observed on surgical removal of adrenal glands (ADX:
adrenalectomy) (Yarushkina, 2008). Nevertheless, it is important to
point out that the observed effects of ADX on pain response are
ambiguous, since, depending on the nature of the pain stimulus, adrenal
removal can increase (Yokoro et al., 2003) or decrease nociceptive
behavior (Vissers et al., 2004).
It has been demonstrated that the exposure of rodents to the
standard elevated plus-maze (sEPM: with two open and two
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1984; Lister, 1987; Pellow et al., 1985), activates the HPA axis,
leading to an enhancement of plasma corticosterone (Rodgers et al.,
1999). The EPM test is based on the natural fear of rodents to open
spaces (Handley andMithani, 1984; Lister, 1987; Pellow et al., 1985).
Animals exposed to the EPM display at least two main strategies:
they 1) avoid the open arms and 2) escape from an open arm to enter
a safer, closed arm (Graeff et al., 1993; Pinheiro et al., 2007). In
addition, Lee and Rodgers (1990) demonstrated that mice exposed
to the EPM not only display defensive behavioral reactions but also
antinociception. In experiments carried out in our laboratory, sEPM-
exposed mice do not show marked antinociception, assessed with
the formalin nociception test. Nevertheless, when mice are placed in
a totally open elevated plus-maze (oEPM: with four open arms) a
marked reduction in the time spent licking the formalin injected paw
(i.e., antinociceptive response) is observed (Mendes-Gomes et al.,
2011; Mendes-Gomes and Nunes-de-Souza, 2005, 2009). Given that
the animals cannot avoid or escape the highly aversive open arms of
the oEPM, this apparatus seems to be a more aversive situation than
the sEPM. Therefore, we hypothesized that oEPM-exposed animals
would exhibit a higher level of corticosterone release than sEPM-
and eEPM-exposed mice. If that hypothesis is correct, oEPM-induced
antinociception (Mendes-Gomes and Nunes-de-Souza, 2005, 2009;
Mendes-Gomes et al., 2011) might be mediated by the release of
corticosterone.
Interestingly, the well-known anxiolytic-like effect produced by
benzodiazepine injections into the dorsal portion of the midbrain
periaqueductal gray matter (dPAG) (Mendes-Gomes and Nunes-de-
Souza, 2005; Russo et al., 1993) was not observed in EPM-exposed
animals that had received a formalin injection (a nociceptive stimulus)
into the hind paw (Mendes-Gomes and Nunes-de-Souza, 2005). A
similar result has also been obtained with chemical lesion of the dPAG
(Mendes-Gomes and Nunes-de-Souza, 2009). Importantly, in both
cases, a clear antianxiety effect was observed in mice that had not
received the prior injection of formalin into the hind paw (Mendes-
Gomes and Nunes-de-Souza, 2005, 2009). Since pain is an aversive
stimulus, it possibly induces the release of corticosterone,which in turn,
may activate limbic brain structures [e.g., amygdala (Carrasquillo and
Gereau, 2007; Ji et al., 2007; Neugebauer et al., 2004; Tanimoto et al.,
2003) and anterior hypothalamus (Lumb, 2004)] responsible for the
mediation of defensive behaviors (e.g., avoidance of the open arms in
the oEPM). In viewof theseﬁndings, in thepresent studywe analyze the
effects of exposure to the enclosed, standard or open EPMon the release
of corticosterone in animals subjected or not subjected to the
nociceptive formalin test. In addition, we analyzed whether the
nociceptive response in the formalin test and oEPM-induced antinoci-
ception are affected by adrenalectomy.
Materials and methods
Subjects
The subjects were male Swiss mice (from Univ. Estadual Paulista -
UNESP, SP, Brazil), weighing 25–35 g. Theywere housed in groups of 7
per cage (41 cm×34 cm×16 cm) and maintained under a 12:12 h
light/dark cycle (lights on at 7:00 a.m.) in a temperature (23±1 °C)
and humidity (55±5%) controlled environment. Food and drinking
water were freely available. All mice were experimentally naïve, and
experimental sessions were carried out during the light phase of the
cycle (9 a.m.–5 p.m.).
Formalin test
Nociception was assessed by the formalin test as previously
described (Abbott et al., 1995). The formalin test causes a two-phase
nociceptive response (Dubuisson and Dennis, 1977). The ﬁrst phasebegins immediately after formalin injection and lasts approximately
5 min. It results from the direct stimulation of nociceptors (Dubuisson
and Dennis, 1977; McCall et al., 1996). The second phase begins
20 min after the injection and lasts approximately 40 min (Bon et al.,
2002). This phase is caused by C-ﬁber activation (McCall et al., 1996;
Tjolsen et al., 1992) and also involves a period of sensitization during
which inﬂammatory phenomena occur (Le Bars et al., 2001; Tjolsen et
al., 1992). In response to formalin injection into the paw, animals
exhibit pain- or recuperative-related behaviors as lifting/guarding
and licking and biting (Bon et al., 2002; Dubuisson and Dennis, 1977;
Sufka et al., 1998). Nevertheless, in the present study only the time
spent licking the formalin-injected paw was used as nociceptive
response.
Apparatus
The basic elevated plus-maze design was similar to that originally
validated formice (Lister, 1987). The standard EPM (sEPM) consisted of
two open arms (30 cm×5 cm×0.25 cm) and two enclosed arms
(30 cm×5 cm×15 cm) connected to a common central platform
(5 cm×5 cm). The apparatus was constructed from wood (ﬂoor) and
transparent glass (clear walls) and was raised to a height of 38.5 cm
above ﬂoor level. The other two mazes were similarly constructed, but
comprised either four enclosed arms (eEPM) or four open arms (oEPM).
On the sEPM, mice were individually placed on the central
platform of the maze facing the left open arm. Both the eEPM and
oEPM were similarly positioned in the experimental room and the
experimenter placed the animal facing the arm that corresponded in
direction to the sEPM left open arm, even though the eEPM had no
open arms and the oEPM no enclosed arms. Between subjects, the
mazes were cleaned thoroughly with 20% ethanol and a dry cloth. All
sessions were video-recorded by a camera linked to a monitor and
DVD in the adjacent laboratory.
Corticosterone radioimmunoassay
The radioimmunoassay for corticosterone was conducted as de-
scribed previously by our research group (Marin et al., 2007). The assay
was performed with antibodies from Sigma (St. Louis, MO) and (3H)-
corticosterone from New England Nuclear (Boston, MA). The method
was adapted from that described by Sarnyai et al. (1992). Brieﬂy, 20 μl of
plasmawas diluted 50 timeswith 0.01 MPBS andplaced in awater bath
at 75 °C for 1 h to heat-inactivate the corticosteroid-binding globulin.
Aliquots of 100 μl of a solution of antibody and (3H)-corticosterone
(10,000 to 20,000 cpm/ml) were added to each sample, mixed and
incubated overnight at 4 °C. Dextran-coated charcoal was used to
adsorb free steroid after incubation. Tubes were centrifuged at 2000 ×g
for 10 min at 4 °C, and the supernatant from each tube was transferred
to a scintillation vial. Radioactivity was measured by liquid scintillation
spectrometry. Standard curves were constructed using 31.25, 62.5, 125,
250, 500 and 1000 pg/100 μl (triplicates) of corticosterone (Sigma).
After dilution, all the concentrations of the corticosterone samples were
within the linear range of the standard curve. The lower limit of
detectionwas 0.23 μg/dl and inter- and intra-assay variationswere 4.0%
and 8.1%, respectively.
Procedures
Experiment 1: Corticosterone levels in mice exposed to different types of
elevated plus-maze: inﬂuence of nociceptive stimulation
Swiss male mice (n=6–9/group) were transported to the experi-
mental room and left undisturbed for at least 60 min prior to testing. In
half of the animals, 50 μl of 2.5% formaldehyde solutionwas injected into
thedorsal surface of the right hindpawand themousewas immediately
placed in an individual glass holding cage (30 cm×20 cm×25 cm).
After an interval of 25 min, each animal was exposed to the eEPM, sEPM
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injected paw was noted over a period of 10 min (25–35min after
formalin injection). Inorder to investigatewhether corticosterone levels
are changed by nociceptive stimulation, the other half of themice were
subjected to a similar procedure, except that they did not receive the
formalin injection (eEPM, sEPM and oEPM, n=8, 9 and 6, respectively).
It is important to highlight that all animals were randomly distributed
between the groups.
After EPM exposure, each mouse was individually placed in a cage
lined with its cage bedding and left undisturbed for 5 min. This time
was based on work in our laboratory demonstrating that a peak in
corticosterone secretion occurs 5 to 10 min after exposure to two
different anxiety/fear tests, the rat exposure test (Amaral et al., 2010)
and the sEPM (personal communication, Karina Santos Gomes). The
animals were then rapidly transported to an adjacent room where
they were decapitated. Trunk blood was collected in heparinized
tubes and centrifuged at 2000 ×g for 10 min, at 4 °C. The plasma was
stored at −80 °C until the radioimmunoassay. An additional group
composed by experimentally naïve mice (corticosterone basal group,
n=5) was placed in individual home cages and followed the same
protocol.30
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b 666Experiment 2: Inﬂuence of adrenalectomy on oEPM-induced
antinociception
Twenty-four mice were anesthetized with i.p. injected ketamine
(100 mg/kg) and xylazine (10 mg/kg) and both adrenal glands were
removed (adrenalectomy, ADX) by a single dorsal midline incision in
the skin at the level of the kidneys. Sham surgery consisted of a single
dorsal midline incision where the adrenal glands were located but not
removed. All mice (ADX and sham) were given free access to water
and 0.9% NaCl drinking solution, as well as food.
Five days after the ADX or sham procedure, each mouse was
injected with formalin as described above. After that they were
exposed to the glass box and the time spent licking the paw was
recorded for 5 min (Phase 1 of the formalin test). Twenty-ﬁveminutes
after formalin injection, animals were exposed to the oEPM or eEPM
(n=6/group) and the nociceptive response was recorded for 10 min.0
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Fig. 1. Plasma levels of corticosterone in mice stimulated or not with formalin injection
into the dorsal right hind paw and exposed to three types of mazes (eEPM, sEPM or
oEPM); n=5–9/group. Numbers on the top of each bar represent the respective sample
a,bBehavioral analysis
Videotapes were scored by a highly trained observer using an
ethological analysis software package developed by Dr. Morato's group
at Faculdade de Filosoﬁa, Ciências e Letras de Ribeirão Preto, USP
(Brazil). In addition to recording the time spent licking the formalin-
injected paw (see above), the total number of arm entries (arm
entry=all four paws into anarm)was scored. For groups exposed to the
sEPM, the frequency of enclosed and open arm entries, % open arm
[(open/total)×100] and % open arm time [(open time/300)×100]were
also recorded. Although the duration of the test was 10 min, the data on
exploration of the maze were calculated only during the standard
(Carobrez and Bertoglio, 2005; Lister, 1987; Pellow et al., 1985; Rodgers
and Johnson, 1995) ﬁrst 5 min of the test.size. Pb0.05 versus basal and without formalin eEPM groups, respectively.
Table 1
Effects of exposure to different types of mazes (eEPM, sEPM or oEPM) on total time
spent licking (s) the formalin-injected paw recorded for 10 min during the tonic phase
of this nociceptive test in mice.
Exposure Time spent licking (s)
eEPM 111.5±33.2
sEPM 99.4±23.8
oEPM 7.4±4.7a
n=6/group.
a Pb0.01 versus eEPM and sEPM.Statistics
All results were initially submitted to Levene's test for homoge-
neity of variance.When appropriate, the data were transformed to the
square root or log and then analyzed by Student's t-test for unrelated
samples, one- or two-way analysis of variance (ANOVA) for
independent factors [one-way (effect of nociception or of surgery
type); two-way (factor 1: maze type, factor 2: nociception)]. Non-
parametric data were analyzed by the Mann–Whitney U test. Where
indicated by signiﬁcant F values, group differences were identiﬁed by
Duncan's test. A P-value≤0.05 was required for signiﬁcance.Ethics
The experiments carried out in this study comply with the norms
of the Brazilian Neuroscience and Behavior Society (SBNeC), based on
the US National Institutes of Health Guide for the Care and Use of
Laboratory Animals. Furthermore, all experimental protocols were
analyzed and approved by the local Research Ethics Committee (CEP/
FCF/Car. protocols 20/2005 and 43/2008).Results
Behavioral results
Fig. 1 illustrates the plasma corticosterone (μg/dl) levels of mice in
the control (basal: animals that were neither exposed to any EPM nor
injected with formalin), eEPM-, sEPM- or oEPM-exposed groups that
had or had not received a prior formalin injection into the hind paw.
One-way ANOVA demonstrated a signiﬁcant effect of exposure on
corticosterone levels [F(6,39)=10.44; Pb0.001]. Posterior compari-
sons revealed that all treated groups secreted more corticosterone
than the control basal group. Moreover, the animals not subjected to
the nociceptive test but exposed to the sEPM or oEPM showed higher
levels of this glucocorticoid than the eEPM-exposed mice. Also, mice
exposed to the eEPM and submitted to the formalin test showed
higher levels of corticosterone when compared to that not subjected
to the nociceptive test.
Table 1 shows the time spent licking the paw injected with
formalin, by mice exposed to the eEPM, sEPM and oEPM. One-way
ANOVA followed by Duncan's test revealed that oEPM-exposed mice
showed a signiﬁcantly lower nociceptive response than animals
exposed to the eEPM and sEPM [F(2,15)=12.02; Pb0.01].
Fig. 2 shows that formalin injection changed neither anxiety
indices nor the locomotor activity during the ﬁrst ﬁve minutes of
411J. Mendes-Gomes et al. / Hormones and Behavior 60 (2011) 408–413exposure to the sEPM, relative to groups not subjected to this
nociceptive test [(% open arm entries: t(12)=1.13; P=0.28; % open
arm time: t(12)=0.76; P=0.46 and frequency of enclosed arm
entries: t(12)=−0.03; P=0.97)].
Table 2 shows the total mean numbers of arm entries and time (in
seconds) spent on the central platform during the ﬁrst 5 min of
exposure to the eEPM, sEPM or oEPM in mice with or without prior
formalin injection into the right hind paw. Regarding total arm
entries, two-way ANOVA revealed signiﬁcant changes for the maze
type factor [F(2,33)=31.33; Pb0.001], but not for the nociception
factor [F(1,33)=2.79; P=0.10] or maze type×nociception interac-
tion [F(2,33)=0.25; P=0.78]. Post-hoc comparisons revealed that
animals exposed to the sEPM or oEPM exhibited lower frequencies of
arm entries than the corresponding groups exposed to the eEPM. The
non-parametric Mann–Whitney U test, applied to the time spent on
the central square, revealed that sEPM-exposed animals spent more
time on the square than eEPM-exposed mice, an effect that did notFig. 2. Lack of effect of formalin injection into the dorsal right hind paw (nociceptive
stimulation) on percentages of entries or percentage of open arm time (OA) and
frequency of enclosed arm entries (EE) in the sEPM in mice; n=6–8/group.
Table 2
Total arm entries and time spent in the central square of the enclosed, standard and
open EPM (eEPM, sEPM and oEPM) exhibited by mice tested or not with formalin
injection into the dorsal right hind paw.
Behavior
Exposure Formalin Total arm entries Center time
eEPM Without 32.4±2.4 72.3±6.2
sEPM 18.4±1.2a 129.9±12.8ab
oEPM 17.7±0.5a 74.8±8.1
eEPM With 28.3±2.1 83.2±7.8
sEPM 17.0±1.8a 137.7±11.9a
oEPM 15.2±3.0a 100.0±25.1
n=6–8/group. a,bPb0.05 versus eEPM and oEPM, respectively.depend on prior formalin injection (without formalin: U=5; Z=
−2.66; Pb0.05; with formalin: U=1; Z=−2.72; Pb0.05). More-
over, sEPM-exposed mice that had not received the formalin
injection spent more time on the center square than oEPM-exposed
mice (U=5; Z=2.45; Pb0.05). Additionally, the Mann–Whitney U
test did not show any effect of formalin injection on time spent on the
center square [oEPM (U=14; Z=−1; P=0.32), sEPM (U=21; Z=
−0.39; P=0.70) or oEPM (U=16; Z=−0.32; P=0.75)].
Fig. 3 shows the lack of effect of adrenalectomy (ADX) on time spent
licking the formalin-injected paw inmice during Phase 1 (0–5 min) and
Phase 2 (25–35 min) of the nociceptive test. Phase 1was analyzedwhile
the mice were in the glass holding cage (GC) and Phase 2 was recorded
during the exposure to the enclosed (eEPM) or open (oEPM) mazes.
Student's t-test for unrelated samples revealed that ADX did not change
the nociceptive response (t(22)=−1.01 ; P=0.32) during Phase 1.
Two-wayANOVA for Phase 2 revealed signiﬁcant changes formaze type
factor [F(1,20)=19.25; Pb0.001], but not for surgery factor [F(1,20)=
0.92; P=0.35] ormaze type versus surgery interactions [F(1,20)=0.03;
P=0.87]. Post-hoc comparisons revealed that oEPM-exposed mice
spent less time licking the injected paw than eEPM-exposed mice.
Table 3 illustrates the effects of ADXon total armentries and time (in
seconds) spent on the central platform bymice exposed to the eEPM or
oEPM for 5 min. The Mann–Whitney U test revealed that ADX did not
alter the frequency of arm entries inmice exposed the two types of EPM
(eEPM: U=10.5; Z=1.2; P=0.23; oEPM: U=17.5; Z=−0.08;
P=0.94). Nevertheless, the Mann–Whitney test revealed that oEPM-
exposed mice showed a lower frequency of arm entries than eEPM, in
sham groups alone (sham: U=3.5; Z=2.33; Pb0.05; ADX: U=11.0;0
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Fig. 3. Lack of effects of adrenalectomy (ADX) on time spent licking (s) the paw injected
with 2.5% formalin, recorded during Phase 1 (0–5 min) or Phase 2 (25–35 min) of the
nociceptive test. Phase 1 was analyzed while the mice were in the glass holding cage
(GC) and Phase 2 was recorded during the exposure to the eEPM or oEPM; n=6/group.
aPb0.001 versus eEPM.
Table 3
Lack of effects of adrenalectomy (ADX) on total arm entries and time spent on the
central square of the enclosed and open EPM (eEPM, sEPM and oEPM) exhibited by
mice stimulated with formalin injection into the dorsal right hind paw.
Behavior
Exposure Surgery Total arm entries Center time
eEPM Sham 21.3±2.2 65.5±5.5
oEPM 12.5±2.0a 123.5±16.9a
eEPM ADX 15.5±3.8 65.7±18.0
oEPM 11.3±1.4 134.3±10.2a
n=6/group.
a Pb0.05 versus eEPM.
412 J. Mendes-Gomes et al. / Hormones and Behavior 60 (2011) 408–413Z=1.12; P=0.26). For the time spent on the central square, two-way
ANOVA revealed signiﬁcant changes for themaze type factor [F(1,20)=
21.50; Pb0.001], but not for the surgery factor [F(1,20)=0.16; P=0.69]
or maze type×surgery interactions [F(1,20)=0.15; P=0.70]. Post-hoc
comparisons revealed that oEPM-exposedmice spentmore time on the
center square than corresponding groups exposed to the eEPM.
Discussion
Present results demonstrated that the exposure of mice to any of
three different types of EPM (eEPM, sEPM and oEPM) increases
plasma corticosterone. This effect was more prominent when animals
were exposed to a more aversive situation (e.g., sEPM and oEPM).
Furthermore, formalin injection into the hind paw caused a high
release of plasma corticosterone in mice exposed to the eEPM, sEPM
or oEPM. In addition, the hypothesis that high levels of plasma
corticosterone induced by oEPM exposure wouldmodulate the oEPM-
induced antinociception was not conﬁrmed, since ADX did not alter
the antinociceptive response of mice exposed to this aversive
situation.
We have recently demonstrated that the anxiolytic-like effects
produced by intra-PAG injection of midazolam (Mendes-Gomes and
Nunes-de-Souza, 2005), or by bilateral lesion of the dPAG (Mendes-
Gomes and Nunes-de-Souza, 2009), are abolished by concurrent
nociceptive stimulation in mice. However, it remains unclear how
nociceptive stimulation alters the antianxiety effects of these pro-
cedures. Considering that formalin injection causes an inﬂammatory
response and, as a typical stressor, increases plasma ACTH and
corticosterone (Taylor et al., 1998) which, in turn, may increase
anxiety (Steimer and Driscoll, 2003), we have hypothesized that the
high plasma levels of corticosterone induced by formalin injection
could contribute to the antinociceptive effect observed in oEPM-
exposed mice. In this context, we investigated in this study whether
mice exposed to the eEPM, sEPM or oEPM, with or without a prior
formalin injection, would show differences in plasma corticosterone
levels. As shown in Fig. 1, irrespective of the nociceptive stimulus they
had received, sEPM- and oEPM-exposed mice showed increased
plasma levels of corticosterone, relative to the basal group. It seems
that nociceptive stimulation induced the maximum release of
corticosterone, so that when animals were also subjected to
threatening situations (e.g., sEPM and oEPM), the levels of cortico-
sterone remained unchanged. Thus, it is possible that pain stimulation
produced a maximal physiological response on corticosterone levels
of this species to an aversive experience. This conclusion is
strengthened when we observe the corticosterone levels of eEPM-
exposed mice. This group showed higher corticosterone levels than
eEPM-exposed mice without the formalin injection. Moreover, eEPM-
exposed mice that received the nociceptive stimulation displayed a
similar corticosterone response proﬁle to that observed for sEPM- and
oEPM-exposed mice. In other words, all three groups that had
received the formalin injection showed similar increases in cortico-
sterone levels.
It is important to stress that sEPM- and oEPM-exposed mice that
had not received the nociceptive stimulus exhibited higher secretion
of corticosterone than equivalent eEPM mice, conﬁrming the
aversiveness of the mazes with open arms. Unexpectedly, sEPM-
exposed mice exhibited similar levels of corticosterone compared to
oEPM-exposed animals, suggesting that the experience of mice to a
totally open EPM would not be more aversive than the exposure to a
maze with protected closed arms. However, it is likely that the
exposure to the sEPM has caused a maximal response on corticoste-
rone levels. In this context, it has been shown that circulating
corticosteroids reach a peak within minutes of exposure to aversive
events (Palkovits, 1987). Moreover, there are regulatory mechanisms
which maintain these levels within an appropriate interval as a form
of prevention against deleterious effects to the organism (Muncket al., 1984). One example of thesemechanisms is the regulation of the
HPA axis activity by glucocorticoids; it means that this component
may inhibit its own release (Akil and Morano, 1995).
Present results also showed that even exposure to the control
situation (eEPM) caused an increase in the plasma levels of
corticosterone. A possible explanation for these high levels in the
eEPM-exposed group may that the mice had not been familiarized
with that place. It is likely that this response was due to the novelty
that mice were exposed to. This conclusion has been raised in
previous ﬁndings (Pellow et al., 1985) that demonstrated that a
simple exposure to a novel place, such as the enclosed arm of the
sEPM, increases plasma corticosterone release in rats.
The present study conﬁrmed previous ﬁndings (Cornélio and
Nunes-de-Souza, 2009; Mendes-Gomes and Nunes-de-Souza, 2005,
2009; Mendes-Gomes et al., 2011) demonstrating that only exposure
to the oEPM (but not to the sEPM) induced highly signiﬁcant
antinociception (Table 1). Considering the present results did not
show differences in the plasma levels of corticosterone in sEPM- and
oEPM-exposed mice, we suggest that the release of corticosterone
is not crucially involved in the mediation of oEPM-induced
antinociception.
Supporting this hypothesis, present results also showed that
surgical removal of adrenal glands did not disrupt the oEPM-induced
antinociception. Actually, ADX did not alter nociceptive response
observed even in the ﬁrst phase of the formalin test. In this context,
we have recently demonstrated that ADX changed neither the ﬁrst
phase of the formalin test nor oEPM-induced antinociception in rats
(Cornélio and Nunes-de-Souza, 2009). Whereas previous ﬁndings
have corroborated the inability of ADX to alter the nociceptive
response to the formalin test (e.g., Taylor et al., 1998), contrasting
evidence has emphasized that both phases of nociception response
induced by formalin are decreased in ADX rats (Vissers et al., 2004).
Moreover, Yarushkina (2008) has demonstrated that glucocorticoids
can mediate stress-induced analgesia.
Regarding the anxiety indices and locomotor activity observed in
sEPM-exposed mice, with or without prior formalin injection, present
results showed that nociceptive stimulation did not increase the
avoidance of the open arms. In other words, a similar pattern of maze
explorationwasobserved inmice subjectedor not to thenociceptive test,
suggesting that pain per se does not affect signiﬁcantly the conventional
measures of anxiety (% open arm entries and % open arm time) in the
sEPM. In this context, it has been demonstrated that although exogenous
corticosterone administration increased (Calvo et al., 1998) or decreased
(Andreatini and Leite, 1994; McBlane and Handley, 1994) anxiety-like
behavior in the sEPM, administration of metirapone, a corticosterone
synthesis inhibitor, did not change open arm avoidance (Calvo et al.,
1998; Rodgers et al., 1999), suggesting that endogenous corticosterone
may not be directly involved in mediation of the emotional responses in
the EPM(Calvo et al., 1998). In this context, the present results also show
thatwhile the formalin injection increased the corticosterone response in
all EPM-exposed animals, this effect did not lead to a reduction in the
open arm exploration in sEPM-exposed mice. These apparently
inconsistent results remain to be clariﬁed in further studies.
The behavioral proﬁle of mice exposed to the three types of EPM,
with or without prior formalin injection, was also investigated. As
shown in Table 2, sEPM- and oEPM-exposed mice displayed lower
numbers of arm entries than eEPM-exposed mice. In addition, sEPM-
exposed mice spent more time on the center platform. These results
corroborate previous studies (Mendes-Gomes and Nunes-de-Souza,
2005, 2009; Mendes-Gomes et al., 2011) suggesting reduced locomo-
tion in situations where a potentially aversive stimulus is present (i.e.,
the open arms). A similar behavioral patternwas observed in eEPM-and
oEPM-exposed mice with formalin injection after adrenal removal
(Table 3). Although the total arm entries of oEPM-exposedmice did not
differ from eEPM-exposedmice in ADX animals, the former group spent
more time on the center platform, emphasizing the aversiveness of the
413J. Mendes-Gomes et al. / Hormones and Behavior 60 (2011) 408–413open arms. Finally, it is also important to point out that neither
nociceptive stimulation nor ADX surgery produced substantial changes
in locomotion or in time spent on the central square in mice exposed to
any of the three types of EPM.
In conclusion, the present study suggests that corticosterone does not
exert a crucial role in themodulation of oEPM-induced antinociception. In
addition, the lack of anxiolytic-like effects observed in earlier work in
whichmice subjected to thenociceptive test and injectedwithmidazolam
into the PAG (Mendes-Gomes and Nunes-de-Souza, 2005) or had this
midbrain structure bilaterally lesioned (Mendes-Gomes and Nunes-de-
Souza, 2009) is unlikely to be due to the release of this glucocorticoid.
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